REG - Goldman Sachs & Co. Avadel Pharma plc - 38.5b - AVADEL PHARMACEUTICALS PLC
Goldman Sachs & Co. LLC disclosed dealings in Avadel Pharmaceuticals PLC under Rule 38.5(b) of the Irish Takeover Panel Act, 1997. The disclosure includes details of interests, short positions, and transactions in USD 0.01 ordinary shares of Avadel Pharmaceuticals. The disclosure is part of the Irish Takeover Panel's requirements and involves various purchases and sales of securities, derivatives, and options. Goldman Sachs acts as an advisor to Avadel Pharmaceuticals in this context.
London Stock Exchange·